Sort   by:  
 Page size 
UnknownLow-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.
Not available
S-EPMC6105329 | biostudies-literature
UnknownEffectiveness of early intensive therapy on β-cell preservation in type 1 diabetes.
Not available
S-EPMC3836135 | biostudies-literature
UnknownAntigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Not available
S-EPMC3580128 | biostudies-literature
UnknownThe effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis.
Not available
S-EPMC3643224 | biostudies-literature
UnknownInterleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Not available
S-EPMC3827771 | biostudies-literature
UnknownCo-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC3462593 | biostudies-literature
UnknownUse of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.
Not available
S-EPMC4677115 | biostudies-literature
UnknownA new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Not available
S-EPMC4302258 | biostudies-literature
UnknownEffect of rituximab on human in vivo antibody immune responses.
Not available
S-EPMC3659395 | biostudies-literature
UnknownIdentical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
Not available
S-EPMC6341285 | biostudies-literature
Sort   by:  
 Page size